• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

草药摄入对房颤患者华法林治疗时间治疗范围内的影响。

Effect of herbal consumption on time in therapeutic range of warfarin therapy in patients with atrial fibrillation.

机构信息

Division of Cardiology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, China.

出版信息

J Cardiovasc Pharmacol. 2011 Jul;58(1):87-90. doi: 10.1097/FJC.0b013e31821cd888.

DOI:10.1097/FJC.0b013e31821cd888
PMID:21558883
Abstract

It has been established that herbal intake affects the anticoagulation effects of warfarin, but the long-term impact on anticoagulation control is unclear. We sought to investigate the effect of concomitant herbal intake on anticoagulation control in patients with nonvalvular atrial fibrillation (AF) treated with warfarin. The effects of common herbs were determined by monitoring the international normalized ratio in 250 patients with AF (69 ± 10 years, 50% male). All the patients had been prescribed warfarin therapy for at least 6 months before enrollment, and their dietary intake, including the type and the frequency of common herbs, was recorded using a standardized questionnaire. Up to 50% of the patients reported consumption of foods with herbal ingredients, including garlic (80.4%), ginger (74.8%), green tea (50.4%), and papaya (55.2%) but rarely herbal drugs such as danshen (1.2%), dong guai (0.8%), fenugreek (1.2%), psyllium seed (0.4%), and ginseng (4%). Infrequent users (1 kind of herb for <4 times per week and nonusers) were more likely to have an international normalized ratio within the optimal therapeutic range (2.0-3.0) than frequent users (>1 kind of herb for ≥4 times per week) (58.1% vs 51.1%, P = 0.046). In conclusion, the patients with AF treated with warfarin had little knowledge about the potential interaction of herbal substances in foods with warfarin. The patients who consumed common herbs at least 4 times per week had suboptimal anticoagulation control with warfarin.

摘要

已经证实,草药摄入会影响华法林的抗凝效果,但长期对抗凝控制的影响尚不清楚。我们旨在研究非瓣膜性心房颤动(AF)患者同时服用草药对接受华法林治疗的抗凝控制的影响。通过监测 250 例 AF 患者(69±10 岁,50%为男性)的国际标准化比值来确定常见草药的影响。所有患者在入组前至少接受了 6 个月的华法林治疗,并且使用标准化问卷记录了他们的饮食摄入,包括常见草药的类型和频率。高达 50%的患者报告食用了含有草药成分的食物,包括大蒜(80.4%)、生姜(74.8%)、绿茶(50.4%)和木瓜(55.2%),但很少食用草药药物,如丹参(1.2%)、当归(0.8%)、葫芦巴(1.2%)、车前子(0.4%)和人参(4%)。与频繁使用者(每周≥4 种草药)相比,偶尔使用者(每周<4 种草药)的国际标准化比值更有可能处于最佳治疗范围内(58.1% vs 51.1%,P=0.046)。总之,接受华法林治疗的 AF 患者对食物中草药物质与华法林潜在相互作用的认识不足。每周至少食用 4 次常见草药的患者,华法林抗凝控制不佳。

相似文献

1
Effect of herbal consumption on time in therapeutic range of warfarin therapy in patients with atrial fibrillation.草药摄入对房颤患者华法林治疗时间治疗范围内的影响。
J Cardiovasc Pharmacol. 2011 Jul;58(1):87-90. doi: 10.1097/FJC.0b013e31821cd888.
2
Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.老年房颤患者(包括有跌倒和/或早期痴呆症的患者)预防卒中的抗凝治疗:一项单中心、回顾性、观察性研究。
Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002.
3
Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study.临床环境中房颤患者华法林治疗的抗凝控制质量及监测成本:一项多中心管理式医疗研究
Ann Pharmacother. 2005 Mar;39(3):446-51. doi: 10.1345/aph.1E169. Epub 2005 Feb 8.
4
[Anticoagulation treatment in real-life practice of patient with nonvalvular atrial fibrillation in Beijing city].[北京市非瓣膜性心房颤动患者现实生活中的抗凝治疗]
Zhonghua Yi Xue Za Zhi. 2007 Sep 4;87(33):2328-31.
5
Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.预测房颤患者在住院环境中使用华法林的因素。
Am J Cardiovasc Drugs. 2010;10(1):37-48. doi: 10.2165/11318870-000000000-00000.
6
Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.口服抗凝强度对心房颤动患者卒中严重程度及死亡率的影响。
N Engl J Med. 2003 Sep 11;349(11):1019-26. doi: 10.1056/NEJMoa022913.
7
Atrial fibrillation and stroke prevention with warfarin in the long-term care setting.长期护理环境中使用华法林预防心房颤动和中风
Arch Intern Med. 1997 May 12;157(9):978-84.
8
Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.心力衰竭恶化对抗凝的影响:一项前瞻性、观察性、试点队列研究。
Clin Ther. 2010 Mar;32(3):506-14. doi: 10.1016/j.clinthera.2010.03.001.
9
Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.在门诊抗凝诊所进行的心房颤动抗凝治疗开放标签前瞻性研究的结果。
Clin Ther. 2004 Sep;26(9):1470-8. doi: 10.1016/j.clinthera.2004.09.002.
10
Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.固定小剂量华法林、常规剂量华法林及阿司匹林对心房颤动患者国际标准化比值(INR)及凝血酶原片段1 + 2的影响。
Thromb Haemost. 1997 May;77(5):845-8.

引用本文的文献

1
Concurrent use of Chinese herbal medicine and anticoagulants may reduce major bleeding events.同时使用中药和抗凝剂可能会减少大出血事件。
PLoS One. 2022 Aug 23;17(8):e0271965. doi: 10.1371/journal.pone.0271965. eCollection 2022.
2
Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA-AF registry.达比加群在中国上市后心房颤动的卒中预防变化:GLORIA-AF注册研究
J Arrhythm. 2020 Mar 10;36(3):408-416. doi: 10.1002/joa3.12321. eCollection 2020 Jun.
3
Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation.
探讨心房颤动患者口服抗凝药物持续性的方法学考虑。
Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):251-260. doi: 10.1093/ehjcvp/pvaa052.
4
Which Benefits and Harms of Using Fenugreek as a Galactogogue Need to Be Discussed during Clinical Consultations? A Delphi Study among Breastfeeding Women, Gynecologists, Pediatricians, Family Physicians, Lactation Consultants, and Pharmacists.在临床咨询中需要讨论使用胡芦巴作为催乳剂的哪些益处和危害?一项针对哺乳期妇女、妇科医生、儿科医生、家庭医生、泌乳顾问和药剂师的德尔菲研究。
Evid Based Complement Alternat Med. 2018 Apr 23;2018:2418673. doi: 10.1155/2018/2418673. eCollection 2018.
5
Engineering a short-chain dehydrogenase/reductase for the stereoselective production of (2S,3R,4S)-4-hydroxyisoleucine with three asymmetric centers.工程化一种短链脱氢酶/还原酶,用于立体选择性生产具有三个不对称中心的 (2S,3R,4S)-4-羟基异亮氨酸。
Sci Rep. 2017 Oct 20;7(1):13703. doi: 10.1038/s41598-017-13978-w.
6
Quality of anticoagulation control among patients with atrial fibrillation: An experience of a tertiary care center in Saudi Arabia.心房颤动患者抗凝控制质量:沙特阿拉伯一家三级医疗中心的经验。
J Saudi Heart Assoc. 2016 Oct;28(4):239-43. doi: 10.1016/j.jsha.2016.02.001. Epub 2016 Feb 11.
7
Continuation of dabigatran therapy in "real-world" practice in Hong Kong.达比加群疗法在香港“真实世界”实践中的延续情况。
PLoS One. 2014 Aug 1;9(8):e101245. doi: 10.1371/journal.pone.0101245. eCollection 2014.
8
Use of home remedies: a cross-sectional survey of patients in Germany.家庭疗法的使用:对德国患者的横断面调查
BMC Fam Pract. 2014 Jun 11;15:116. doi: 10.1186/1471-2296-15-116.
9
The co-use of conventional drugs and herbs among patients in Norwegian general practice: a cross-sectional study.挪威全科医疗中患者同时使用传统药物和草药的情况:一项横断面研究。
BMC Complement Altern Med. 2013 Oct 30;13:295. doi: 10.1186/1472-6882-13-295.
10
A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines.抗凝/抗血小板药物与中草药之间潜在有害相互作用的综述。
PLoS One. 2013 May 9;8(5):e64255. doi: 10.1371/journal.pone.0064255. Print 2013.